Influence of Age, Sepsis and SLCO1A2 Polymorphisms on Rocuronium Pharmacokinetics

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
SepsisSystemic Inflammatory Response SyndromeSeptic Shock
Interventions
PROCEDURE

Serial blood sampling

Serial blood samples are being collected at times 0, 2, 5, 10, 15, 20, 30, 60, 120, 180, 240 and 360 minutes after rocuronium administration.

PROCEDURE

Train of four monitoring

Neuromuscular blockade is being evaluated at the same time of blood sampling by stimulation of the adductor muscle of the thumb on the ulnar nerve through the train of four monitoring (TOF).

PROCEDURE

Blood testing for liver and renal function

Blood testing: urea, creatinine, aspartate aminotransferase, alanine aminotransferase, albumin, glycemia

DRUG

General anesthesia

All patients were induced with individual intravenous doses of midazolam, rocuronium, fentanyl and propofol.

PROCEDURE

Small to medium sized surgery under general anesthesia

Patients classified according American Society of Anesthesiologists (ASA) as ASA I-III and submitted to small-medium sized surgery under general anesthesia were recruited for the present investigation.

Trial Locations (1)

14801902

Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara

All Listed Sponsors
collaborator

University of Sao Paulo

OTHER

lead

Universidade Estadual Paulista Júlio de Mesquita Filho

OTHER

NCT02399397 - Influence of Age, Sepsis and SLCO1A2 Polymorphisms on Rocuronium Pharmacokinetics | Biotech Hunter | Biotech Hunter